Neuroone Medical Technologies (NMTC) Capital Expenditures (2019 - 2026)
Neuroone Medical Technologies (NMTC) posted Capital Expenditures of $38516.0 for Q1 2026, down 5.49% on a QoQ basis from $40754.0 in Q4 2025, and up 1114.63% year-over-year from $3171.0 in Q1 2025.
Neuroone Medical Technologies (NMTC) Capital Expenditures (2019 - 2026) Analysis & Trends
Neuroone Medical Technologies' Capital Expenditures history runs 8 years deep, the most recent figure standing at $38516.0 for Q1 2026.
- Quarterly Capital Expenditures rose 1114.63% year-over-year to $38516.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $133425.0 (up 68.27% YoY) and the FY2025 annual result came in at $81742.0, down 31.99% from the prior year.
- Capital Expenditures was $38516.0 for Q1 2026 at Neuroone Medical Technologies, down from $40754.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $175694.0 in Q1 2023 and bottomed at $3171.0 in Q1 2025.
- A 5-year average of $51709.5 and a median of $38516.0 in 2026 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2025 — Capital Expenditures slumped 89.89% — and 2026, when it jumped 1114.63%.
- Neuroone Medical Technologies' Capital Expenditures stood at $11512.0 in 2022, then surged by 222.54% to $37131.0 in 2023, then tumbled by 34.24% to $24416.0 in 2024, then surged by 66.92% to $40754.0 in 2025, then retreated by 5.49% to $38516.0 in 2026.
- Business Quant data shows NMTC's Capital Expenditures at $38516.0 in Q1 2026, $40754.0 in Q4 2025, and $10607.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | 38,516.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38,516.00 |
| Mar 31, 2026 | 38,516.00 |
| Dec 31, 2025 | 40,754.00 |
| Dec 31, 2025 | 40,754.00 |
| Sep 30, 2025 | 10,607.00 |
| Sep 30, 2025 | 10,607.00 |
| Jun 30, 2025 | 43,548.00 |
| Jun 30, 2025 | 43,548.00 |
| Mar 31, 2025 | 3,171.00 |
| Mar 31, 2025 | 3,171.00 |
| Dec 31, 2024 | 24,416.00 |
| Dec 31, 2024 | 24,416.00 |
| Sep 30, 2024 | 36,905.00 |
| Sep 30, 2024 | 36,905.00 |
| Jun 30, 2024 | 14,801.00 |
| Jun 30, 2024 | 14,801.00 |
| Mar 31, 2024 | 31,360.00 |
| Mar 31, 2024 | 31,360.00 |
| Dec 31, 2023 | 37,131.00 |
| Dec 31, 2023 | 37,131.00 |